Public demand for AstraZeneca vaccine falls in Britain after blood clot scares

Public preference for the coronavirus vaccine developed by AstraZeneca and the University of Oxford has fallen since reports potentially linking it to some cases of unusual blood clotting events. A study of almost 5,000 adults in April in the U.K. has found that ...

from Google Alert - Business https://ift.tt/32TAKSX
Public preference for the coronavirus vaccine developed by AstraZeneca and the University of Oxford has fallen since reports potentially linking it to some cases of unusual blood clotting events. A study of almost 5,000 adults in April in the U.K. has found that ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize